163 related articles for article (PubMed ID: 21072979)
1. Antiretroviral drug development for HIV: challenges for the future.
Boone LR; Koszalka GW
Curr Opin Investig Drugs; 2010 Aug; 11(8):863-67. PubMed ID: 21072979
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Current status and challenges of antiretroviral research and therapy.
Esté JA; Cihlar T
Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.
Hatano H; Hunt P; Weidler J; Coakley E; Hoh R; Liegler T; Martin JN; Deeks SG
Clin Infect Dis; 2006 Nov; 43(10):1329-36. PubMed ID: 17051502
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of HIV-1 resistance.
Paredes R; Clotet B
Antiviral Res; 2010 Jan; 85(1):245-65. PubMed ID: 19808056
[TBL] [Abstract][Full Text] [Related]
7. Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs.
Perno CF; Moyle G; Tsoukas C; Ratanasuwan W; Gatell J; Schechter M
J Med Virol; 2008 Apr; 80(4):565-76. PubMed ID: 18297706
[TBL] [Abstract][Full Text] [Related]
8. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.
Trono D; Van Lint C; Rouzioux C; Verdin E; Barré-Sinoussi F; Chun TW; Chomont N
Science; 2010 Jul; 329(5988):174-80. PubMed ID: 20616270
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistant human immunodefiency virus.
Kozal MJ
Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
[TBL] [Abstract][Full Text] [Related]
10. HIV chemotherapy.
Richman DD
Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
[TBL] [Abstract][Full Text] [Related]
11. Running a tightrope: regulatory challenges in the development of antiretrovirals.
Naeger LK; Struble KA; Murray JS; Birnkrant DB
Antiviral Res; 2010 Jan; 85(1):232-40. PubMed ID: 19665489
[TBL] [Abstract][Full Text] [Related]
12. Eradication of HIV in infected patients: some potential approaches.
Yang QE
Med Sci Monit; 2004 Jul; 10(7):RA155-65. PubMed ID: 15232518
[TBL] [Abstract][Full Text] [Related]
13. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection.
Fischl MA
AIDS; 1999 Sep; 13 Suppl 1():S49-59. PubMed ID: 10546785
[TBL] [Abstract][Full Text] [Related]
15. Maturation inhibitors: a new therapeutic class targets the virus structure.
Salzwedel K; Martin DE; Sakalian M
AIDS Rev; 2007; 9(3):162-72. PubMed ID: 17982941
[TBL] [Abstract][Full Text] [Related]
16. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
Wilson LE; Gallant JE
Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
[TBL] [Abstract][Full Text] [Related]
18. New antiretrovirals and new combinations.
Havlir DV; Lange JM
AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
20. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.
Grant PM; Zolopa AR
Curr Opin Investig Drugs; 2010 Aug; 11(8):901-10. PubMed ID: 20721832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]